Overview
Dr. Shi is a gastrointestinal (GI)/liver pathologist. Her particular areas of interest are GI and pancreatic neuroendocrine tumors and pancreatic pathology. Her research interests include 1) Pathobiology of GI and pancreatic neuroendocrine tumors and 2) Identification of diagnostic, prognostic and therapeutic biomarkers for colorectal and pancreatic cancers
Current Duke Appointments & Affiliations
Professor of Pathology
·
2021 - Present
Pathology,
Clinical Science Departments
Member of the Duke Cancer Institute
·
2020 - Present
Duke Cancer Institute,
Institutes and Centers
Recent Scholarly Works
Changes in the 6th edition of the World Health Organization classification of tumours of the digestive system.
Journal article Histopathology · June 2026 The 6th Edition of the WHO Classification of Digestive System Tumours represents a significant update to the 5th edition. It integrates pathological, new molecular, and clinical insights to refine the taxonomy of digestive system neoplasms. The revised cla ... Full text Link to item CiteSerotonin Expression and β-Cell Phenotype Are Associated With Indolent Behavior in Pancreatic Neuroendocrine Tumors With Sclerosing Morphology.
Journal article J Surg Oncol · June 2026 BACKGROUND AND OBJECTIVES: ARX and PDX1 transcription factors have been considered indicators of the cell of origin for pancreatic neuroendocrine tumors (PanNETs). Some PanNETs show dense fibrosis (sclerosing morphology) and an association with serotonin e ... Full text Link to item Cite733 Increased Age, Peritoneal Disease and Post-operative Mesenteric Mass Indicate Poor Prognosis in Resected Stage IV Jejunal/ileal Neuroendocrine Tumors
Conference Laboratory Investigation · March 2026 Full text CiteRecent Grants
Biomarker validation for intraductal papillary mucinous neoplasms of the pancreas
ResearchInvestigator · Awarded by National Cancer Institute · 2018 - 2028View All Grants
Education
Dalhousie University (Canada) ·
2002
Ph.D.
Zhejiang University (China) ·
1989
M.D.